News
A lab study in Nature Cancer links the spatial immune landscape of metastatic triple-negative breast tumors to immunotherapy response.
Christina Curtis elected a Fellow of the AACR Academy, recognizing scientists whose work has driven major breakthroughs in cancer research.
Christina Curtis awarded the 2025 Memorial Sloan Kettering Paul Marks Prize for Cancer Research, for computational approaches to tumor evolution and breast cancer subtyping.
Christina Curtis honored with the ESMO Award for Translational Research (European Society for Medical Oncology), for pioneering work linking cancer genomics to clinical decision-making.
Postdoctoral fellow Maryam Pourmaleki named a 2025 Cancer Research Institute Immuno-Informatics Fellow (Mark Foundation Fellow), supporting her computational immuno-oncology research in the lab.
A lab study in Nature finds how breast cancers are broadly defined by their genome architecture.
Postdoctoral fellow Seongyeol Park awarded a 2025 Cancer Research Institute Immuno-Informatics Fellowship (Dr. Keith Landesman Memorial Fellowship) to study cancer-immune co-evolution in metastatic breast cancer.
Christina Curtis received two top breast-cancer honors at the San Antonio Breast Cancer Symposium — the AACR Outstanding Investigator Award for Breast Cancer Research (AACR / Breast Cancer Research Foundation) and the Susan G. Komen Brinker Award for Scientific Distinction — becoming the first person to earn both in a single year.
A lab study in Science shows how a person's inherited genome shapes which breast cancers develop and turn aggressive.
Postdoctoral fellow Debra Van Egeren received a 2024 A.P. Giannini Foundation Postdoctoral Research Fellowship to study how inflammation drives structural variation in premalignant gastric tissue.
A lab study in Nature reveals cancer's “origin story” — the earliest steps toward cancer follow a predictable path.
Christina Curtis received the AACR Award for Outstanding Achievement in Basic Cancer Research, recognizing work on tumor evolution including the “Big Bang” model.
Christina Curtis named a Chan Zuckerberg Biohub Investigator.
Christina Curtis leads a Stanford center in the NCI Metastasis Research Network (MetNet), studying the evolutionary dynamics and microenvironmental drivers of metastatic breast cancer.
Christina Curtis awarded the Stanford Prize in Population Genetics and Society.
A lab study in Nature Genetics shows that colorectal cancers are often “born to be bad,” spreading before diagnosis.
Christina Curtis awarded the NIH Director's Pioneer Award.
Christina Curtis named a Kavli Frontier of Science Fellow by the National Academy of Sciences.
A lab study in Nature Genetics introduces the “Big Bang” model of tumor growth, in which a tumor's fate is largely set early.